Literature DB >> 18461119

Exploring Emotion-Regulation and Autonomic Physiology in Metastatic Breast Cancer Patients: Repression, Suppression, and Restraint of Hostility.

Janine Giese-Davis1, Ansgar Conrad, Bita Nouriani, David Spiegel.   

Abstract

We examined relationships between three emotion-regulation constructs and autonomic physiology in metastatic breast cancer patients (N = 31). Autonomic measures are not often studied in breast cancer patients and may provide evidence of an increase in allostatic load. Patients included participated as part of a larger clinical trial of supportive-expressive group therapy. Systolic and diastolic blood pressure and heart rate were assessed at a semi-annual follow-up. We averaged 3 resting assessments and used measures of Repression, Suppression, Restraint of Hostility, and Body Mass Index as predictors of autonomic response. We found that higher repression was significantly associated with higher diastolic blood pressure, while higher restraint of hostility was significantly associated with higher systolic blood pressure. A repressive emotion regulation style may be a risk factor for higher sympathetic activation possibly increasing allostatic load, while restraint of hostility may be a protective factor for women with metastatic breast cancer.

Entities:  

Year:  2008        PMID: 18461119      PMCID: PMC2836882          DOI: 10.1016/j.paid.2007.08.002

Source DB:  PubMed          Journal:  Pers Individ Dif        ISSN: 0191-8869


  50 in total

1.  Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy.

Authors:  Janine Giese-Davis; Cheryl Koopman; Lisa D Butler; Catherine Classen; Matthew Cordova; Pat Fobair; Jane Benson; Helena C Kraemer; David Spiegel
Journal:  J Consult Clin Psychol       Date:  2002-08

2.  EMOTIONS IN CARDIOVASCULAR DISEASE.

Authors:  M FRIEDMAN; R H ROSENMAN
Journal:  Heart Bull       Date:  1964 Mar-Apr

3.  Natural history of male psychological health, XII: a 45-year study of predictors of successful aging at age 65.

Authors:  G E Vaillant; C O Vaillant
Journal:  Am J Psychiatry       Date:  1990-01       Impact factor: 18.112

4.  Anger suppression, reactivity, and hypertension risk: gender makes a difference.

Authors:  C Vögele; A Jarvis; K Cheeseman
Journal:  Ann Behav Med       Date:  1997

5.  Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: The Chicago Heart Association Detection Project in Industry Study.

Authors:  K Miura; A R Dyer; P Greenland; M L Daviglus; M Hill; K Liu; D B Garside; J Stamler
Journal:  Hypertension       Date:  2001-08       Impact factor: 10.190

6.  Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study.

Authors:  B M Psaty; C D Furberg; L H Kuller; M Cushman; P J Savage; D Levine; D H O'Leary; R N Bryan; M Anderson; T Lumley
Journal:  Arch Intern Med       Date:  2001-05-14

7.  Sex differences in social support, self-deception, hostility, and ambulatory cardiovascular activity.

Authors:  W Linden; L Chambers; J Maurice; J W Lenz
Journal:  Health Psychol       Date:  1993-09       Impact factor: 4.267

8.  The discrepant repressor: differentiation between low anxiety, high anxiety, and repression of anxiety by autonomic-facial-verbal patterns of behavior.

Authors:  J B Asendorpf; K R Scherer
Journal:  J Pers Soc Psychol       Date:  1983-12

9.  Myocardial ischemia during daily activities: the importance of increased myocardial oxygen demand.

Authors:  A Hinderliter; P Miller; E Bragdon; M Ballenger; D Sheps
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

10.  Anger-coping types, blood pressure, and all-cause mortality: a follow-up in Tecumseh, Michigan (1971-1983).

Authors:  M Julius; E Harburg; E M Cottington; E H Johnson
Journal:  Am J Epidemiol       Date:  1986-08       Impact factor: 4.897

View more
  8 in total

1.  Emotional acceptance, inflammation, and sickness symptoms across the first two years following breast cancer diagnosis.

Authors:  Rebecca G Reed; Karen L Weihs; David A Sbarra; Elizabeth C Breen; Michael R Irwin; Emily A Butler
Journal:  Brain Behav Immun       Date:  2016-02-23       Impact factor: 7.217

2.  Is expressive suppression harmful for Chinese American breast cancer survivors?

Authors:  Qian Lu; William Tsai; Qiao Chu; Jing Xie
Journal:  J Psychosom Res       Date:  2018-03-29       Impact factor: 3.006

3.  Which symptoms matter? Self-report and observer discrepancies in repressors and high-anxious women with metastatic breast cancer.

Authors:  Janine Giese-Davis; Rie Tamagawa; Maya Yutsis; Suzanne Twirbutt; Karen Piemme; Eric Neri; C Barr Taylor; David Spiegel
Journal:  J Behav Med       Date:  2012-10-20

4.  Emotional Regulation in Young Adults with Internet Gaming Disorder.

Authors:  Ju-Yu Yen; Yi-Chun Yeh; Peng-Wei Wang; Tai-Ling Liu; Yun-Yu Chen; Chih-Hung Ko
Journal:  Int J Environ Res Public Health       Date:  2017-12-25       Impact factor: 3.390

5.  Psychological Factors as Determinants of Chronic Conditions: Clinical and Psychodynamic Advances.

Authors:  Ciro Conversano; Mariagrazia Di Giuseppe
Journal:  Front Psychol       Date:  2021-01-28

6.  Retrospective Analyses of Psychological Distress and Defense Style Among Cancer Patients.

Authors:  Ciro Conversano; Mariagrazia Di Giuseppe; Mario Miccoli; Rebecca Ciacchini; Annarita Di Silvestre; Rosa Lo Sterzo; Angelo Gemignani; Graziella Orrù
Journal:  Clin Neuropsychiatry       Date:  2020-08

Review 7.  Emotions and Emotion Regulation in Breast Cancer Survivorship.

Authors:  Claire C Conley; Brenden T Bishop; Barbara L Andersen
Journal:  Healthcare (Basel)       Date:  2016-08-10

8.  Defense Mechanisms and Repressive Coping Among Male Breast Cancer Patients.

Authors:  Rainer Weber; Johannes C Ehrenthal; Evamarie Brock-Midding; Sarah Halbach; Rachel Würstlein; Christoph Kowalski; Nicole Ernstmann
Journal:  Front Psychiatry       Date:  2021-12-10       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.